Tarsadia Capital, LLC Bluebird Bio, Inc. Transaction History

Tarsadia Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$11.24 - $21.0 $1.12 Million - $2.1 Million	-100,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$16.59 - $33.89 $319,457 - $652,585	19,256 Added 23.85%	100,000 $3.02 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $569,520 - $965,370	21,000 Added 35.15%	80,744 $4.93 Million
Q1 2020 May 14, 2020	BUY	$26.16 - $63.5 $1.56 Million - $3.79 Million	59,744 New	59,744 $2.75 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Tarsadia Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Tarsadia Capital, LLC with notifications on news.